Renaissance Technologies LLC Has $2.67 Million Holdings in Walgreens Boots Alliance Inc (WBA)

Renaissance Technologies LLC lowered its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 97.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 36,800 shares of the pharmacy operator’s stock after selling 1,189,810 shares during the quarter. Renaissance Technologies LLC’s holdings in Walgreens Boots Alliance were worth $2,672,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in the business. MYDA Advisors LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $363,000. Moors & Cabot Inc. boosted its holdings in shares of Walgreens Boots Alliance by 26.9% in the fourth quarter. Moors & Cabot Inc. now owns 27,107 shares of the pharmacy operator’s stock valued at $1,974,000 after acquiring an additional 5,754 shares in the last quarter. Scotia Capital Inc. boosted its holdings in shares of Walgreens Boots Alliance by 7.9% in the fourth quarter. Scotia Capital Inc. now owns 145,066 shares of the pharmacy operator’s stock valued at $10,535,000 after acquiring an additional 10,565 shares in the last quarter. Wayne Hummer Investments L.L.C. boosted its holdings in shares of Walgreens Boots Alliance by 104.5% in the fourth quarter. Wayne Hummer Investments L.L.C. now owns 49,493 shares of the pharmacy operator’s stock valued at $3,594,000 after acquiring an additional 25,296 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of Walgreens Boots Alliance by 11.0% in the fourth quarter. Caisse DE Depot ET Placement DU Quebec now owns 7,547,745 shares of the pharmacy operator’s stock valued at $548,117,000 after acquiring an additional 748,442 shares in the last quarter. Institutional investors own 60.87% of the company’s stock.

Shares of NASDAQ:WBA opened at $65.00 on Wednesday. The company has a market cap of $63,387.26, a P/E ratio of 12.75, a price-to-earnings-growth ratio of 1.03 and a beta of 1.16. Walgreens Boots Alliance Inc has a 1-year low of $61.74 and a 1-year high of $87.79. The company has a quick ratio of 0.45, a current ratio of 0.90 and a debt-to-equity ratio of 0.44.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.18. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. The firm had revenue of $33.02 billion during the quarter, compared to analyst estimates of $32.20 billion. During the same quarter last year, the business posted $1.36 EPS. The company’s revenue was up 12.1% on a year-over-year basis. sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 5.95 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 12th. Investors of record on Friday, May 18th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.46%. The ex-dividend date is Thursday, May 17th. Walgreens Boots Alliance’s dividend payout ratio is 31.37%.

Several research analysts have recently issued reports on WBA shares. Bank of America started coverage on shares of Walgreens Boots Alliance in a report on Tuesday, February 27th. They issued a “neutral” rating and a $76.00 price objective for the company. Pivotal Research decreased their price objective on shares of Walgreens Boots Alliance from $73.00 to $69.00 and set a “hold” rating for the company in a report on Friday, March 23rd. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $76.00 price objective for the company in a report on Wednesday, February 14th. Jefferies Group set a $85.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a report on Tuesday, April 3rd. Finally, BidaskClub cut shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Thursday, March 22nd. One analyst has rated the stock with a sell rating, ten have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $83.20.

COPYRIGHT VIOLATION NOTICE: “Renaissance Technologies LLC Has $2.67 Million Holdings in Walgreens Boots Alliance Inc (WBA)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/04/25/renaissance-technologies-llc-has-2-67-million-holdings-in-walgreens-boots-alliance-inc-wba.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply